Argent Biopharma Ltd (RGT) — Cash Flow Quality Index
Argent Biopharma Ltd (RGT) has a Cash Flow Quality Index of -4.11x as of September 2018. Operating cash flow of AU$-1.34 Million is below net income of AU$326.24K, suggesting accrual-heavy earnings not yet converted to cash. Explore RGT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Argent Biopharma Ltd Cash Flow Quality Index (2006–2011)
Historical Cash Flow Quality Index for Argent Biopharma Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Argent Biopharma Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Argent Biopharma Ltd (2006–2011)
Year-by-year earnings quality comparison for Argent Biopharma Ltd. For live market cap and the full company financial profile, see market value of Argent Biopharma Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2011 | -0.18x | AU$-338.82K | AU$1.94 Million | ▼ -180.3% |
| 2006 | 0.22x | AU$41.00K | AU$188.00K | — |